192 related articles for article (PubMed ID: 8762312)
1. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx.
Zidar N; Gale N; Cör A; Kambic V
J Laryngol Otol; 1996 May; 110(5):440-5. PubMed ID: 8762312
[TBL] [Abstract][Full Text] [Related]
2. Quantitative pathology of laryngeal epithelial hyperplastic lesions.
Cör A; Gale N; Kambic V
Acta Otolaryngol Suppl; 1997; 527():57-61. PubMed ID: 9197483
[TBL] [Abstract][Full Text] [Related]
3. Expression of proliferating cell nuclear antigen in premalignant lesions of the larynx.
Zhao R; Hirano M; Kurita S
Am J Otolaryngol; 1996; 17(1):36-44. PubMed ID: 8801814
[TBL] [Abstract][Full Text] [Related]
4. [Value of monoclonal antibodies (PC 10, MIB1, p53 and LeuM 1) for assessing the prognosis of patients with squamous epithelial carcinoma of the larynx after partial laser resection].
Hake R; Eckel H; von Pritzbuer E; Volling P; Thiele J
Pathologe; 1995 May; 16(3):197-203. PubMed ID: 7792271
[TBL] [Abstract][Full Text] [Related]
5. Potential biomarkers in predicting progression of epithelial hyperplastic lesions of the larynx.
Gallo O; Franchi A; Chiarelli I; Porfirio B; Grande A; Simonetti L; Bocciolini C; Fini-Storchi O
Acta Otolaryngol Suppl; 1997; 527():30-8. PubMed ID: 9197477
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szkudlarek T; Jeleń-Krzeszewska J
Oral Oncol; 1999 Mar; 35(2):180-6. PubMed ID: 10435153
[TBL] [Abstract][Full Text] [Related]
7. [An immunohistochemical study of proliferating cell nuclear antigen (PCNA) and MIB-1 in epithelial hyperplasia and dysplasia of the vocal cords].
Urano M; Iwata S; Takasu A; Mori S; Sakurai K; Katoh H; Yamamoto S; Kasahara M; Kuroda M; Hakuno T
Nihon Jibiinkoka Gakkai Kaiho; 1996 Mar; 99(3):395-401. PubMed ID: 8934774
[TBL] [Abstract][Full Text] [Related]
8. DNA index, cellular proliferative activity and nucleolar organizer regions in cancers of the larynx.
Cappiello J; Nicolai P; Antonelli AR; Facchetti F; Cadei M; Cornacchiari A; Grigolato PG
Eur Arch Otorhinolaryngol; 1995; 252(6):353-8. PubMed ID: 8679155
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor, c-erbB-2 and p53 overexpressions in epithelial hyperplastic lesions of the larynx.
Gale N; Zidar N; Kambic V; Poljak M; Cör A
Acta Otolaryngol Suppl; 1997; 527():105-10. PubMed ID: 9197495
[TBL] [Abstract][Full Text] [Related]
10. [The meaning of the expression of PCNA and c-erbB-2 in the hyperplasia of laryngeal epithelium].
Yao Q; Lu X; Huang Z; Cao Y; Jiang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Jun; 13(6):263-4. PubMed ID: 12563981
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA) expression in laryngeal squamous cell carcinomas. An immunohistochemical study.
Kram A; Domagała W
Pol J Pathol; 1996; 47(4):183-7. PubMed ID: 9097710
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
13. [Expression of proliferating cell nuclear antigen (PCNA) in premalignant lesions of laryngeal epithelium].
Zhou G; Lin D; Liang C
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):206-8. PubMed ID: 8745457
[TBL] [Abstract][Full Text] [Related]
14. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.
Shin DM; Voravud N; Ro JY; Lee JS; Hong WK; Hittelman WN
J Natl Cancer Inst; 1993 Jun; 85(12):971-8. PubMed ID: 8098774
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
[TBL] [Abstract][Full Text] [Related]
16. Morphometric analysis of Ki-67 and p16 expression in laryngeal precursor lesions.
Pavlovic B; Djukic V; Milovanovic J; Tomanovic N; Milovanovic A; Trivic A
Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1405-10. PubMed ID: 23408022
[TBL] [Abstract][Full Text] [Related]
17. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
[TBL] [Abstract][Full Text] [Related]
18. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemically stained markers (p53, PCNA, bcl-2) in dysplastic lesions of the larynx.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Szkudlarek T; Szajowski K
Cancer Lett; 1999 Aug; 143(1):23-8. PubMed ID: 10465333
[TBL] [Abstract][Full Text] [Related]
20. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers.
Welkoborsky HJ; Hinni M; Dienes HP; Mann WJ
Ann Otol Rhinol Laryngol; 1995 Jul; 104(7):503-10. PubMed ID: 7598360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
